94M

6-chloro-9-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]-9H-purin-2-amine

Created:	2010-07-30
Last modified:	2022-09-28

Find Related PDB Entry
5 entries where 94M is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	37
Chiral Atom Count	0
Bond Count	39
Aromatic Bond Count	16

2D diagram of 94M

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	6-chloro-9-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]-9H-purin-2-amine
Synonyms	BIIB021
Systematic Name (OpenEye OEToolkits)	6-chloro-9-[(4-methoxy-3,5-dimethyl-pyridin-2-yl)methyl]purin-2-amine
Formula	C₁₄ H₁₅ Cl N₆ O
Molecular Weight	318.762
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	Clc3nc(nc1c3ncn1Cc2ncc(c(OC)c2C)C)N
SMILES	CACTVS	3.370	COc1c(C)cnc(Cn2cnc3c(Cl)nc(N)nc23)c1C
SMILES	OpenEye OEToolkits	1.7.0	Cc1cnc(c(c1OC)C)Cn2cnc3c2nc(nc3Cl)N
Canonical SMILES	CACTVS	3.370	COc1c(C)cnc(Cn2cnc3c(Cl)nc(N)nc23)c1C
Canonical SMILES	OpenEye OEToolkits	1.7.0	Cc1cnc(c(c1OC)C)Cn2cnc3c2nc(nc3Cl)N
InChI	InChI	1.03	InChI=1S/C14H15ClN6O/c1-7-4-17-9(8(2)11(7)22-3)5-21-6-18-10-12(15)19-14(16)20-13(10)21/h4,6H,5H2,1-3H3,(H2,16,19,20)
InChIKey	InChI	1.03	QULDDKSCVCJTPV-UHFFFAOYSA-N

Drug Info: DrugBank

DrugBank ID	DB12359
Name	BIIB021
Groups	investigational
Description	BIIB021 has been investigated for the treatment of Tumors and Lymphoma.
Synonyms	Biib021 Mesylate BIIB021
Categories	Heterocyclic Compounds, Fused-Ring HSP90 Heat-Shock Proteins, antagonists & inhibitors Purines
CAS number	848695-25-0

Related Resource References

Resource Name	Reference
Pharos	CHEMBL467399
PubChem	16736529
ChEMBL	CHEMBL467399
ChEBI	CHEBI:90687
CCDC/CSD	QOCCIX

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.